Related Experiment Videos
Deep brain stimulation in movement disorders. The applications reconsidered
V Visser-Vandewalle1, Y Temel, Ch van der Linden
1Dept of Neurosurgery, University Hospital Maastricht, Maastricht, The Netherlands. vva@snch.azm.nl
Acta Neurologica Belgica
|May 18, 2004
Summary
Deep brain stimulation (DBS) shows mixed results for advanced Parkinson disease (PD). Bilateral subthalamic nucleus stimulation offers significant motor improvement, while unilateral pallidal stimulation is less effective for PD.
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Deep brain stimulation (DBS) is an established therapy for advanced Parkinson disease (PD).
- Re-evaluation of existing DBS techniques and exploration of new indications are crucial for optimizing patient care.
Purpose of the Study:
- To re-evaluate the efficacy of unilateral pallidal stimulation in advanced PD.
- To explore new indications for DBS in movement disorders, including multiple system atrophy-parkinsonism (MSA-P) and Tourette syndrome (TS).
Main Methods:
- Unilateral pallidal stimulation in 26 advanced PD patients.
- Bilateral subthalamic nucleus (STN) stimulation in 20 advanced PD patients.
- Bilateral STN stimulation in 4 MSA-P patients.
- Literature review and bilateral thalamic stimulation in 3 TS patients.
Main Results:
- Unilateral pallidal stimulation yielded unsatisfying motor effects in advanced PD.
- Bilateral STN stimulation in advanced PD resulted in significant long-term motor and functional improvement, with some patients experiencing hypomanic/manic side effects.
- Bilateral STN stimulation improved outcomes in MSA-P patients.
- Bilateral thalamic stimulation in TS led to the disappearance of major tics and associated behavioral disturbances.
Conclusions:
- Unilateral pallidal stimulation is not recommended for advanced PD.
- Bilateral STN stimulation is a favorable option for advanced PD, despite potential mood-related side effects.
- DBS shows promise for MSA-P and presents a novel therapeutic option for Tourette syndrome.